XORTX Therapeutics (XRTX) Q2 2024 Earnings

20MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-1.24
-0.83
-0.41
0

Details

Expected EPS
-0.448403
Actual EPS
-1.24
Surprise EPS
-0.79
Surprise Percent
+176.54%

Description

XORTX Therapeutics (XRTX) has reported earnings of -1.24 per share for Q2 2024.

0 Comments

Share your thoughts